Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:OGN
NYSE:OGNPharmaceuticals

Organon Draws Sun Offer As NEXPLANON Decision Reframes Value Debate

Sun Pharmaceutical has submitted a nonbinding offer to acquire Organon (NYSE:OGN). Organon recently received FDA approval for extended duration use of NEXPLANON with a new REMS safety program. These developments affect Organon’s women’s health portfolio and potential ownership structure. Organon, trading at $8.54, is coming into focus as both a deal target and a women’s health player with a newly approved product label. The share price is up 19.1% over the past 30 days and 18.0% year to...
TSE:6305
TSE:6305Machinery

Hitachi Construction Machinery (TSE:6305) Margin Compression Challenges Bullish Earnings Growth Narratives

Hitachi Construction Machinery (TSE:6305) has put fresh numbers on the table for Q3 2026, reporting revenue of ¥325.3 billion and basic EPS of ¥86.76, with net income excluding extraordinary items at ¥18,456 million. The company has seen quarterly revenue move between ¥325.3 billion and ¥380.0 billion over the last six reported periods, while basic EPS has ranged from ¥31.96 to ¥140.12. This gives investors a broad view of how earnings power tracks against a relatively steady top line and...
TSX:EFX
TSX:EFXEnergy Services

A Look At Enerflex (TSX:EFX) Valuation After Energy Transition Focus And Management Changes

Recent attention on Enerflex (TSX:EFX) has centered on its role in natural gas compression and processing, its involvement in energy transition projects, and management changes that have brought its current valuation under closer investor scrutiny. See our latest analysis for Enerflex. Enerflex’s recent share price momentum has been strong, with a 10.72% 7 day share price return and 41.59% 90 day share price return. Its 1 year total shareholder return of 83.91% and 5 year total shareholder...
XTRA:YSN
XTRA:YSNIT

Why secunet Security Networks (XTRA:YSN) Is Up 15.8% After Strong 2025 Outlook Beat And Defence Surge

secunet Security Networks has released preliminary 2025 results showing revenue and order intake at the upper end of its outlook, driven by strong growth in the Public Sector and Defence&Space activities alongside improving trends in the Business Sector. The Management Board’s expectation of further revenue and earnings growth for 2026 underscores how public-sector security demand is increasingly shaping secunet’s business profile. We’ll now look at how secunet’s strong Defence&Space...
NYSE:TTI
NYSE:TTIEnergy Services

Assessing TETRA Technologies (TTI) Valuation After Strong Recent Share Price Momentum

TETRA Technologies (TTI) has drawn fresh attention after a strong share price move over the past month and the past three months, prompting investors to reassess its valuation and recent financial profile. See our latest analysis for TETRA Technologies. That recent share price run, including a 21.66% 30 day share price return and 61.47% 90 day share price return to US$11.40, sits alongside a very strong 1 year total shareholder return of 174.70% and a 5 year total shareholder return above 4x...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Margin Worsening To Q2 Loss Challenges High Growth Narratives

Viavi Solutions (VIAV) has just posted Q2 2026 results with revenue of US$369.3 million and a basic EPS loss of US$0.21, while trailing twelve month figures show revenue of US$1.2 billion and a basic EPS loss of US$0.19. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$369.3 million in Q2 2026, with EPS shifting from a profit of US$0.04 to a loss of US$0.21 as margins compressed. See our full analysis for Viavi Solutions. With the latest numbers...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Net Margin Improvement Tests Justification For Premium P/E Valuation

How ABB (SWX:ABBN)'s FY 2025 Numbers Set the Stage ABB (SWX:ABBN) closed FY 2025 with fourth quarter revenue of US$9.1b and basic EPS of US$0.70, alongside trailing twelve month revenue of US$33.2b and EPS of US$2.50 that frame the full year picture. Over recent periods, the company has seen quarterly revenue range from US$7.9b to just over US$9.0b and EPS move from US$0.54 in Q4 2024 through to US$0.70 in Q4 2025, giving investors a clear read on how the top line and per share earnings have...
NasdaqGS:SILC
NasdaqGS:SILCCommunications

Silicom (SILC) Quarterly Losses Persist Challenging Bullish Profitability Narratives

Silicom (SILC) closed FY 2025 with Q4 revenue of US$16.9 million and a basic EPS loss of US$0.44, alongside net income excluding extra items of a US$2.5 million loss, putting another loss-making quarter on the scoreboard. Over recent periods the company has seen quarterly revenue move from US$14.5 million in Q4 2024 through US$14.4 million in Q1 2025, US$15.0 million in Q2, and US$15.6 million in Q3. Quarterly basic EPS stayed in loss territory, ranging from a US$1.05 loss per share in Q4...
ENXTPA:ETL
ENXTPA:ETLMedia

Will France Blocking Eutelsat’s Antenna Sale Recast Eutelsat Communications' (ENXTPA:ETL) Protected Infrastructure Narrative

Earlier this week, French Finance Minister Roland Lescure blocked Eutelsat’s planned sale of its ground antennas, key infrastructure used for both civilian and military satellite communications, leading the company to confirm that its disposal agreement with EQT Infrastructure VI will not proceed. The decision reinforces Eutelsat’s role as the only European rival to Starlink and highlights how governments may treat satellite networks as critical national assets. We will now consider how the...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Vera Therapeutics Adds CCO As Atacicept Advances And Valuation Gap Persists

Vera Therapeutics (NasdaqGM:VERA) has appointed Matt Skelton as Chief Commercial Officer. The move comes as the company prepares for potential commercialization of its lead drug, atacicept, for IgA nephropathy. Atacicept has received Breakthrough Therapy Designation and Priority Review from the FDA. Vera Therapeutics focuses on therapies for serious immunologic diseases, with atacicept as its lead asset in IgA nephropathy. The addition of a Chief Commercial Officer signals that management...
ASX:NAB
ASX:NABBanks

Has National Australia Bank (ASX:NAB) Run Too Far After Strong Multi‑Year Share Gains

Wondering if National Australia Bank is reasonably priced at its current level, or if the recent run means you might be paying too much for the stock. The share price recently closed at A$43.37, with returns of 2.4% over the past week, 2.5% over the past month, 2.3% year to date and 12.8% over the last year, while the 3 year and 5 year returns sit at 57.9% and 119.3%. These moves sit against a backdrop of ongoing interest in the big Australian banks and regular updates on credit conditions,...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

Could New PFOF Rules Quietly Reshape eToro Group’s (ETOR) Core Competitive Edge?

Recent industry attention on eToro Group has focused on how upcoming regulatory changes, including MiFID II amendments, DORA enforcement and a Payment-for-Order-Flow ban, are set to redefine operating standards for digital brokerage platforms. These shifts are expected to raise the bar on transparency, resilience and data connectivity, offering larger players such as eToro an opportunity to deepen user engagement and reinforce trust through stronger compliance and richer account aggregation...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

AGNC Balances Strong Returns With More Cautious 2026 Investment Approach

AGNC Investment (NasdaqGS:AGNC) reported robust full-year economic returns for 2025. The company continued its high-yield monthly dividend policy, keeping the payout in double-digit territory. Management outlined a more cautious capital deployment and selective investment approach for 2026. The shift is linked to changing mortgage market conditions, including tighter spreads and prepayment risks. AGNC Investment (NasdaqGS:AGNC) focuses on mortgage backed securities, so shifts in mortgage...
NYSE:MATX
NYSE:MATXShipping

A Look At Matson (MATX) Valuation After Strong Preliminary Q4 Results And Steady 2026 Outlook

Matson’s latest results and dividend decision Matson (MATX) shares are in focus after the company reported preliminary fourth quarter results that surpassed expectations, supported by stronger freight rates and volumes in its China service. See our latest analysis for Matson. Matson’s strong preliminary fourth quarter update and recent dividend declaration come after a sharp 58.79% 90 day share price return. The 5 year total shareholder return of 166.31% points to longer term compounding,...
TSX:FOM
TSX:FOMMetals and Mining

A Look At Foran Mining (TSX:FOM) Valuation After Hitting A New Yearly High On Project Progress And Sentiment

Why Foran Mining Is Back on Investors’ Radar Foran Mining (TSX:FOM) recently touched a new yearly high, drawing fresh attention to its copper and zinc projects along Saskatchewan’s Flin Flon Greenstone Belt, including the flagship McIlvenna Bay development. See our latest analysis for Foran Mining. The latest pullback, including a 7.18% 1 day share price decline to CA$6.59, follows a strong run, with a 30 day share price return of 30.75% and a 1 year total shareholder return of 73.42%. This...
NasdaqGM:LAND
NasdaqGM:LANDSpecialized REITs

A Look At Gladstone Land (LAND) Valuation After Preferred Redemption Plan And Earnings Update

Gladstone Land (LAND) is back in focus after confirming continued monthly cash distributions, setting a redemption date of January 30, 2026, for all Series D Preferred Stock, and scheduling its upcoming fourth quarter 2025 earnings release. See our latest analysis for Gladstone Land. The recent announcements on monthly distributions, preferred share redemption and the upcoming earnings release come after a strong run in the stock, with a 30 day share price return of 21.86% and a year to date...
BIT:TPRO
BIT:TPROSemiconductor

A Look At Technoprobe (BIT:TPRO) Valuation After Sector Jitters From Intel AI Chip Supply Warning

Weakness across semiconductor stocks after Intel flagged supply constraints for AI server chips has put Technoprobe (BIT:TPRO) back in focus, as investors weigh sector driven sentiment against the company’s recent share performance. See our latest analysis for Technoprobe. After a softer recent patch linked to sector wide worries, Technoprobe’s share price has a 30 day share price return of 28.11% and a 90 day share price return of 66.28%. The 1 year total shareholder return of 155.81% and 3...
TSXV:SICO
TSXV:SICOMetals and Mining

A Look At Silverco Mining (TSXV:SICO) Valuation After The CA$40 Million Follow On Equity Offering

Silverco Mining (TSXV:SICO) has filed a follow on equity offering to raise CA$40 million by issuing 3,200,000 common shares at CA$12.50. This move directly affects the company’s capital structure and liquidity. See our latest analysis for Silverco Mining. The follow on equity offering comes after a steep 1 day share price return of negative 12.84% and a 7 day share price return of negative 9.46%. However, the 90 day share price return of 211.61% and 30 day share price return of 15.79%...
ASX:MLX
ASX:MLXMetals and Mining

Does Near‑Record Renison Tin Output And Lower Costs Change The Bull Case For Metals X (ASX:MLX)?

Metals X recently reported near-record tin production at its Renison mine for the December quarter, supported by higher mined grades, improved efficiencies and a record monthly output in December. This operational performance also drove lower cash production costs and more than doubled imputed EBITDA versus the prior quarter, highlighting the financial impact of the productivity gains. We’ll now examine how Renison’s improved efficiencies and near-record tin output shape Metals X’s broader...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

VSE (VSEC) Valuation Check After Strong Share Price Momentum And Long Term Shareholder Returns

Why VSE (VSEC) Is On Investors’ Radar Today VSE (VSEC) has caught investor attention after a strong recent share price move, with the stock showing solid gains over the month and the past 3 months. This performance has prompted some investors to take a closer look at its fundamentals. See our latest analysis for VSE. That recent momentum sits on top of a longer run, with a 30 day share price return of 26.51% and a very large 5 year total shareholder return of 544.71%. This suggests sentiment...
NYSE:LEA
NYSE:LEAAuto Components

Lear’s New GM T1XX Win Reshapes Future Revenue And Supplier Role

Lear (NYSE:LEA) has secured General Motors' T1XX program at the Orion plant. The program was previously operated by Magna, with Lear set to begin production in 2027. This award represents a shift in supplier responsibilities on a key GM vehicle program. Lear is a major automotive supplier, best known for seating and electronic systems that go into a wide range of vehicles. Winning the GM T1XX program at Orion from a rival supplier puts fresh attention on how automakers are allocating core...
LSE:LLOY
LSE:LLOYBanks

Lloyds Banking Group (LSE:LLOY) Valuation Check After Strong Recent Share Price Returns

Why Lloyds Banking Group is on investor watchlists today Lloyds Banking Group (LSE:LLOY) has drawn fresh interest after recent share price gains over the month and past 3 months, prompting investors to reassess how its current valuation lines up with fundamentals. See our latest analysis for Lloyds Banking Group. Recent trading has been strong, with a 1 day share price return of 3.32% and a 90 day share price return of 22.31%. The 1 year total shareholder return of 83.53% and 5 year total...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA (KLAC) Net Margin At 35.8% Tests Justification For Premium Earnings Narrative

KLA (KLAC) has just posted Q2 2026 results with revenue of US$3.3 billion and basic EPS of US$8.73, alongside trailing twelve month revenue of US$12.7 billion and EPS of US$34.55 that sit against a 42.1% earnings rise over the past year. Over recent quarters the company has seen revenue move from US$3.1 billion in Q2 2025 to US$3.3 billion in Q2 2026, while quarterly basic EPS shifted from US$6.18 to US$8.73. This sets up the latest report against a backdrop of faster trailing earnings growth...